Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Plos Pathogens|October 21, 2016
Kingella kingae Expresses Four Structurally Distinct Polysaccharide Capsules That Differ in Their Correlation with Invasive DiseaseKimberly F Starr, Eric A Porsch, Patrick C Seed, et al.Journal of Clinical Medicine|October 28, 2023
Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation-One-Year SurvivalShmuel Tiosano, Ariel Banai, Wesam Mulla, et al.Radiation Oncology (London, England)|August 11, 2023
Radiation dose is associated with improved local control for large, but not small, hepatocellular carcinomasUri Amit, Jahan J Mohiuddin, Andrzej P Wojcieszynski, et al.Practical Radiation Oncology|October 10, 2017
Use of 18F-FDG PET-CT imaging to determine internal mammary lymph node location for radiation therapy treatment planning in breast cancer patientsTima Davidson, Merav Ben-David, Shira Galper, et al.International Journal of Cardiology|November 6, 2015
Macrophages dictate the progression and manifestation of hypertensive heart diseaseDavid Kain, Uri Amit, Chana Yagil, et al.Surgical Oncology|August 15, 2024
The effect of long-standing lymphopenia after radiation therapy on survival in rectal cancerViacheslav Soyfer, Eli Lugovoy, Alla Nikolaevski-Berlin, et al.Nuclear Medicine Communications|July 26, 2019
Gallium-68 prostate-specific membrane antigen PET-CT and the clinical management of prostate cancerTima Davidson, Uri Amit, Akram Saad, et al.Proceedings of the National Academy of Sciences of the United States of America|July 24, 2024
Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancerUri Amit, Ugur Uslu, Ioannis I Verginadis, et al.Cancer|June 14, 2025
A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resectable pancreatic cancerUri Amit, James M Metz, John P Plastaras, et al.Journal of Neuro-Oncology|June 21, 2021
A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade gliomaKeren Porper, Yael Shpatz, Luba Plotkin, et al.Pageof 5